Potassium Chloride
- Product NDC
- 62037-999
- 11-digit product format
- 620370999
- Labeler code
- 62037
- Product ID
- 62037-999_24e96f7f-1458-4117-aa6c-590d027bf8b3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- potassium chloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA076368
- Marketing category
- ANDA
- Marketing start
- 2004-08-18
- Marketing end
- 0000-00-00
- Substance
- POTASSIUM CHLORIDE
- Active strength
- 20 meq/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| ETHYLCELLULOSE (100 MPA.S) | INACTIVE INGREDIENT | 47MLB0F1MV | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BLENHIEM PHARMACAL, INC.] | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BLENHIEM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BLENHIEM PHARMACAL, INC.] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BLENHIEM PHARMACAL, INC.] | 1 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BLENHIEM PHARMACAL, INC.] | 1 | |
| ETHYLCELLULOSE (100 MPA.S) | INACTIVE INGREDIENT | 47MLB0F1MV | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BLENHIEM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [BLENHIEM PHARMACAL, INC.] | 1 | |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62037-999-01 | 62037099901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-999-01) | 2004-08-18 | 0000-00-00 | No | No | Current |
| 62037-999-05 | 62037099905 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-999-05) | 2004-08-18 | 0000-00-00 | No | No | Current |
| 62037-999-10 | 62037099910 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-999-10) | 2004-08-18 | 0000-00-00 | No | No | Current |
| 62037-999-90 | 62037099990 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-999-90) | 2016-04-27 | 0000-00-00 | No | No | Current |